Overexpression of the 5-hydroxytryptamine transporter gene - Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension

被引:152
作者
MacLean, MR [1 ]
Deuchar, GA
Hicks, MN
Morecroft, I
Shen, SB
Sheward, J
Colston, J
Loughlin, L
Nilsen, M
Dempsie, Y
Harmar, A
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Glasgow, Dept Med Cardiol, Glasgow G12 8QQ, Lanark, Scotland
[3] Univ Edinburgh, Div Neurosci, Edinburgh EH8 9YL, Midlothian, Scotland
关键词
hypertension; pulmonary; hypoxia; remodeling; risk factors; genes;
D O I
10.1161/01.CIR.0000127375.56172.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Increased serotonin (5-hydroxytryptamine, 5-HT) transporter activity has been observed in human familial pulmonary hypertension. Methods and Results - We investigated pulmonary hemodynamics and the development of hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in mice overexpressing the gene for the 5-HT transporter (5-HTT + mice). Right ventricular pressure was elevated 3-fold in normoxic 5-HTT + mice compared with their wild-type controls. Hypoxia-induced increases in right ventricular hypertrophy and pulmonary vascular remodeling were also potentiated in the 5-HTT+ mice. 5-HTT - like immunoreactivity, protein, and binding sites were markedly increased in the lungs from the 5-HTT+ mice. Hypoxia, however, decreased 5-HT transporter immunoreactivity, mRNA transcription, protein, and binding sites in both wild-type and 5-HTT + mice. Conclusions - Increased 5-HT transporter expression causes elevated right ventricular pressures, and this occurs before the onset of right ventricular hypertrophy or pulmonary arterial remodeling. Hypoxia-induced remodeling is, however, increased in 5-HTT + mice, whereas hypoxia inhibits 5-HTT expression. This provides a unique model that demonstrates differential mechanisms for familial pulmonary arterial hypertension and pulmonary arterial hypertension with hypoxemia.
引用
收藏
页码:2150 / 2155
页数:6
相关论文
共 32 条
[21]   5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats [J].
MacLean, MR ;
Sweeney, G ;
Baird, M ;
McCulloch, KM ;
Houslay, M ;
Morecroft, I .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (05) :917-930
[22]   Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension [J].
Marcos, E ;
Adnot, S ;
Pham, MH ;
Nosjean, A ;
Raffestin, B ;
Hamon, M ;
Eddahibi, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (04) :487-493
[23]   CHRONIC HYPOXIC PULMONARY-HYPERTENSION IN RATS AND INCREASED ELASTOLYTIC ACTIVITY [J].
MARUYAMA, K ;
YE, CL ;
WOO, M ;
VENKATACHARYA, H ;
LINES, LD ;
SILVER, MM ;
RABINOVITCH, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :H1716-H1726
[24]   HYPOXIA-INDUCED INCREASED PERMEABILITY OF ENDOTHELIAL MONOLAYERS OCCURS THROUGH LOWERING OF CELLULAR CAMP LEVELS [J].
OGAWA, S ;
KOGA, S ;
KUWABARA, K ;
BRETT, J ;
MORROW, B ;
MORRIS, SA ;
BILEZIKIAN, JP ;
SILVERSTEIN, SC ;
STERN, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :C546-C554
[25]   [H-3] CITALOPRAM BINDING TO BRAIN AND PLATELET MEMBRANES OF HUMAN AND RAT [J].
PLENGE, P ;
MELLERUP, ET .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (01) :248-252
[26]   RAT PULMONARY CIRCULATION AFTER CHRONIC HYPOXIA - HEMODYNAMIC AND STRUCTURAL FEATURES [J].
RABINOVITCH, M ;
GAMBLE, W ;
NADAS, AS ;
MIETTINEN, OS ;
REID, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 236 (06) :H818-H827
[27]   Novel variants of murine serotonin transporter mRNA and the promoter activity of its upstream site [J].
Sakai, K ;
Hasegawa, C ;
Okura, M ;
Morikawa, O ;
Ueyama, T ;
Shirai, Y ;
Sakai, N ;
Saito, N .
NEUROSCIENCE LETTERS, 2003, 342 (03) :175-178
[28]  
Sharma SK, 1999, J PHARMACOL EXP THER, V290, P1475
[29]   Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes [J].
Shen, SB ;
Battersby, S ;
Weaver, M ;
Clark, E ;
Stephens, K ;
Harmar, AJ .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (01) :75-78
[30]   Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice [J].
Shen, SB ;
Spratt, C ;
Sheward, WJ ;
Kallo, I ;
West, K ;
Morrison, CF ;
Coen, CW ;
Marston, HM ;
Harmar, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11575-11580